Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.48
-1.00%
Mkt Cap $285.57M
EPS — Estimate vs Actual
Mkt Cap
$285.57M
P/E
—
Fwd P/E
—
P/S
45.21
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.48
-1.00%
Mkt Cap $285.57M
Mkt Cap
$285.57M
P/E
—
Fwd P/E
—
P/S
45.21
Rev TTM
—
EPS TTM
-$1.09